Screener
Bristol-Myers Squibb BMY Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
Based on trailing twelve months.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's asset turnover?
- Bristol-Myers Squibb (BMY) reported asset turnover of 0.5× in Q2 2026.
- How has Bristol-Myers Squibb's asset turnover changed year-over-year?
- Bristol-Myers Squibb's asset turnover increased by 7.1% year-over-year, from 0.5× to 0.5×.
- What is the long-term trend for Bristol-Myers Squibb's asset turnover?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's asset turnover has grown at a 9.0% compound annual growth rate (CAGR), from 0.3× to 0.5×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Bristol-Myers Squibb's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude